Currently, supervisory programs play a significant role in pharma and clinical medicine, allowing further development of medicinal drugs. The study of drug administration in a real clinical practice environment provides new information about its safety and benefits, helps identify administration specifics in different patient groups, interaction with other drugs and may stimulate the process of registration of the drug for new indications.

These programs are implemented only after the drug receives an official registration certificate. They do not interrupt the standard treatment process and are administered as per the instructions for use in compilance with the commonly accepted clinical practice standards. Within such programs there is no need for special procedures or additional visits related to the study: diagnostics and patient treatment are conducted according to usual clinical practice.